Search

everythinglearnresearchcommunity

for

Search:↓

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Scalp micropigmentation is a successful, non-surgical way to make hair look fuller.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Mesothelioma of the tunica vaginalis testis is rare, often high-grade, and has a median survival of about 24 months.

A new classification for depth control in hair restoration surgery was proposed, dividing it into three grades based on the depth required for successful graft extraction.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

The oral supplement with Pinus pinaster and Grape seed extract, used with sunscreen, effectively and safely improved mild-to-moderate facial melasma.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Minoxidil alone is as effective as the combination but has fewer side effects.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Survivors of severe COVID-19 need ongoing care to manage lasting health issues.

Most acne patients were young males with face acne, with many experiencing worsening in summer and diet-related aggravation.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

Platelet-rich plasma (PRP) was found not effective in treating male-patterned hair loss.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Spironolactone successfully treated hair loss in a 9-year-old girl.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.